BioCryst Pharmaceuticals Q1 2025 Earnings Preview
Express News | BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | BioCryst Appoints Steve Frank to Board of Directors
Press Release: BioCryst Appoints Steve Frank to Board of Directors
BioCryst to Present at Upcoming Investor Conferences
Earnings Preview: BCRX to Report Financial Results on May 05
BioCryst Pharmaceuticals Initiated at Overweight by Cantor Fitzgerald
Cantor Fitzgerald Initiates BioCryst Pharmaceuticals(BCRX.US) With Buy Rating, Announces Target Price $20
BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
JMP Securities Maintains BioCryst Pharmaceuticals(BCRX.US) With Buy Rating, Maintains Target Price $18
BioCryst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 5, 2025
BofA Securities Maintains BioCryst Pharmaceuticals(BCRX.US) With Buy Rating, Maintains Target Price $11
Executive Reshuffles: CVS, NNDM, and DBX
RBC Capital Maintains BioCryst Pharmaceuticals(BCRX.US) With Buy Rating, Maintains Target Price $11
Express News | RBC Capital Reiterates Outperform on BioCryst Pharma, Maintains $11 Price Target
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Needham Maintains BioCryst Pharmaceuticals(BCRX.US) With Buy Rating, Maintains Target Price $15
How BioCryst Pharmaceuticals, Inc. (BCRX) Stock Stands Out in a Strong Industry
BioCryst Pharmaceuticals CEO Takes On Finance Duties on Interim Basis